A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected Patients

NCT00000748 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2500

Enrollment

NIH

Sponsor class

Conditions

Pneumonia, Pneumocystis Carinii
HIV Infections

Interventions

DRUG: Sulfamethoxazole-Trimethoprim

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]